erlotinib hydrochloride has been researched along with endothelin-1 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 12,740 | 632 | 3,394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shahrour, F; Alandes, S; Alcácer, J; Aliena-Valero, A; Aparisi, S; Becker, JH; Benet, M; Borgia, JA; Carretero, J; Chuliá-Peris, L; Dalheim, AV; Fernández-Coronado, JA; García-Cañaveras, JC; Juan, O; Kaja, S; Lahoz, A; López, A; Nishimura, MI; Ollosi, S; Pulido, I; Qiu, W; Rodríguez, ML; Salom, JB; Shimamura, T; Soucheray, M; Tamayo-Torres, E | 1 |
1 other study(ies) available for erlotinib hydrochloride and endothelin-1
| Article | Year |
|---|---|
Endothelin-1-Mediated Drug Resistance in
Topics: Animals; Antineoplastic Agents; Biological Availability; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Endothelin-1; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Mice; Mutation; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor A; Vasoconstriction; Xenograft Model Antitumor Assays | 2020 |